🔎 Trials Near Me

መነሻ › የሳንባ መካከለኛ ሕዋስ በሽታዎች › ካንሳስ

በካንሳስ ለየሳንባ መካከለኛ ሕዋስ በሽታዎች የሚደረጉ ክሊኒካዊ ጥናቶች

ለየሳንባ መካከለኛ ሕዋስ በሽታዎች የሚደረጉ 13 ጥናቶች በካንሳስ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በካንሳስ ውስጥ ያሉ ከተሞች

Official study text (English)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • University of Kansas Medical Center, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

  • University of Kansas Medical Center, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07201922

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA002, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07179380

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • University of Kansas Medical Center, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06968845

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07333183

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Kansas Medical Center, Kansas City
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

  • University of Kansas School of Medicine, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • University of Kansas Medical Center, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT06328777

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • The University of Kansas Medical Center Research Institute, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • University of Kansas Medical Center, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT05943535

Interstitial Lung Disease Research Unit Biobank

  • The University of Kansas Medical Center, Kansas City
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁላይ 2026 · NCT05392881

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

  • University of Kansas Medical Center, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ 3 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT04624490

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

  • University of Kansas, Kansas City
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሜይ 2024 · NCT06397677

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።